Medical Device News Magazine

INTEGREON GLOBAL Appoints Michael Hays as New President

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Integreon Global, a family of companies that ensures product integrity and protection through innovative materials, testing services, packaging and monitoring solutions, and contract manufacturing, announced today that Michael Hays has been named President, replacing Maurice Barakat, effective December 5, 2022.  Mr. Barakat will assume the role of Executive Chairman and CEO.

Mr. Hays’ new position is the culmination of several decades of leadership in the expandable polystyrene (EPS) industry, most recently as Vice President of Altor Solutions.  His career path included management roles in business development, finance, and overall enterprise strategy and board level involvement.

As a long-term employee and eventual Division General Manager, he was integral in the growth of his original company, Premier Industries, which was later consolidated with Foam Fabricators and eventually transformed into Altor Solutions.  Through each of these strategic phases, Mr. Hays’ expertise contributed to his teams winning numerous industry awards for clients in the technology, automotive, appliance, construction, and health care sectors.  These accolades culminated with Michael receiving the EPS industry’s prestigious “Lifetime Achievement Award” in 2022.

“Michael is a people-first leader who comes to Integreon Global with a strong track record of expansion, coupled with a reputation for building a world-class packaging manufacturing group.  Michael’s extensive management experience will help our business units accelerate their continuing development as a trusted partner of global manufacturers,” said Maurice Barakat.

“I am proud and honored to become a part of the highly successful Integreon Global family,” said Michael Hays. “This is a wonderful opportunity to both lead and to provide outstanding service to our clients. Integreon has a strong, growing, and diversified suite of business units whose purpose is to protect people and products. The company’s unique blend of skilled experts, advanced materials, and innovative technologies across the entire enterprise positions us perfectly to rise to the challenges of a global marketplace.”

The Integreon group of companies designs and manufactures polymeric foam beads, thermal packaging and monitoring solutions, and provides testing, contract development and manufacturing services.  Integreon operates in four end markets: Pharmaceuticals, life sciences, perishable foods, and foam processors. Each of Integreon’s companies offers custom-engineered solutions and testing services critical to the end-to-end protection and efficient manufacturing of customers’ products.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”